Bonus Biogroup Stock Volatility
BBIXF Stock | USD 0.02 0.00 0.00% |
Bonus BioGroup secures Sharpe Ratio (or Efficiency) of -0.11, which signifies that the company had a -0.11% return per unit of risk over the last 3 months. Bonus BioGroup exposes sixteen different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Bonus BioGroup's Mean Deviation of 1.84, risk adjusted performance of (0.07), and Standard Deviation of 5.95 to double-check the risk estimate we provide. Key indicators related to Bonus BioGroup's volatility include:
30 Days Market Risk | Chance Of Distress | 30 Days Economic Sensitivity |
Bonus BioGroup Pink Sheet volatility depicts how high the prices fluctuate around the mean (or its average) price. In other words, it is a statistical measure of the distribution of Bonus daily returns, and it is calculated using variance and standard deviation. We also use Bonus's beta, its sensitivity to the market, as well as its odds of financial distress to provide a more practical estimation of Bonus BioGroup volatility.
Bonus |
Since volatility provides investors with entry points to take advantage of stock prices, companies, such as Bonus BioGroup can benefit from it. Downward market volatility can be a perfect environment for investors who play the long game as hey may decide to buy additional stocks of Bonus BioGroup at lower prices to lower their average cost per share. Similarly, when the prices of Bonus BioGroup's stock rise, investors can sell out and invest the proceeds in other equities with better opportunities.
Moving together with Bonus Pink Sheet
0.83 | NVO | Novo Nordisk AS | PairCorr |
0.82 | NONOF | Novo Nordisk AS | PairCorr |
0.76 | CSLLY | CSL | PairCorr |
0.67 | CMXHF | CSL Limited | PairCorr |
0.87 | REGN | Regeneron Pharmaceuticals | PairCorr |
0.75 | QSAM | Qsam Biosciences | PairCorr |
Moving against Bonus Pink Sheet
0.84 | AVTE | Aerovate Therapeutics | PairCorr |
0.82 | BAC | Bank of America Fiscal Year End 10th of January 2025 | PairCorr |
0.7 | HNRC | Houston Natural Resources | PairCorr |
0.69 | GOOG | Alphabet Class C Aggressive Push | PairCorr |
0.55 | SLF | Sun Life Financial | PairCorr |
Bonus BioGroup Market Sensitivity And Downside Risk
Bonus BioGroup's beta coefficient measures the volatility of Bonus pink sheet compared to the systematic risk of the entire market represented by your selected benchmark. In mathematical terms, beta represents the slope of the line through a regression of data points where each of these points represents Bonus pink sheet's returns against your selected market. In other words, Bonus BioGroup's beta of 0.37 provides an investor with an approximation of how much risk Bonus BioGroup pink sheet can potentially add to one of your existing portfolios. Bonus BioGroup exhibits very low volatility with skewness of -3.61 and kurtosis of 22.89. Bonus BioGroup is a penny stock. Although Bonus BioGroup may be in fact a good investment, many penny pink sheets are subject to artificial price hype. Make sure you completely understand the upside potential and downside risk of investing in Bonus BioGroup. We encourage investors to look for signals such as message board hypes, claims of breakthroughs, email spams, sudden volume upswings, and other similar hype indicators. We also encourage traders to check biographies and work history of company officers before investing in instruments with high volatility. You can indeed make money on Bonus instrument if you perfectly time your entry and exit. However, remember that penny pink sheets that have been the subject of artificial hype usually unable to maintain their increased share price for more than just a few days. The price of a promoted high volatility instrument will almost always revert back. The only way to increase shareholder value is through legitimate performance backed up by solid fundamentals.
3 Months Beta |Analyze Bonus BioGroup Demand TrendCheck current 90 days Bonus BioGroup correlation with market (Dow Jones Industrial)Bonus Beta |
Bonus standard deviation measures the daily dispersion of prices over your selected time horizon relative to its mean. A typical volatile entity has a high standard deviation, while the deviation of a stable instrument is usually low. As a downside, the standard deviation calculates all uncertainty as risk, even when it is in your favor, such as above-average returns.
Standard Deviation | 6.04 |
It is essential to understand the difference between upside risk (as represented by Bonus BioGroup's standard deviation) and the downside risk, which can be measured by semi-deviation or downside deviation of Bonus BioGroup's daily returns or price. Since the actual investment returns on holding a position in bonus pink sheet tend to have a non-normal distribution, there will be different probabilities for losses than for gains. The likelihood of losses is reflected in the downside risk of an investment in Bonus BioGroup.
Bonus BioGroup Pink Sheet Volatility Analysis
Volatility refers to the frequency at which Bonus BioGroup pink sheet price increases or decreases within a specified period. These fluctuations usually indicate the level of risk that's associated with Bonus BioGroup's price changes. Investors will then calculate the volatility of Bonus BioGroup's pink sheet to predict their future moves. A pink sheet that has erratic price changes quickly hits new highs, and lows are considered highly volatile. A pink sheet with relatively stable price changes has low volatility. A highly volatile pink sheet is riskier, but the risk cuts both ways. Investing in highly volatile security can either be highly successful, or you may experience significant failure. There are two main types of Bonus BioGroup's volatility:
Historical Volatility
This type of pink sheet volatility measures Bonus BioGroup's fluctuations based on previous trends. It's commonly used to predict Bonus BioGroup's future behavior based on its past. However, it cannot conclusively determine the future direction of the pink sheet.Implied Volatility
This type of volatility provides a positive outlook on future price fluctuations for Bonus BioGroup's current market price. This means that the pink sheet will return to its initially predicted market price. This type of volatility can be derived from derivative instruments written on Bonus BioGroup's to be redeemed at a future date.Transformation |
The output start index for this execution was zero with a total number of output elements of sixty-one. Bonus BioGroup Average Price is the average of the sum of open, high, low and close daily prices of a bar. It can be used to smooth an indicator that normally takes just the closing price as input.
Bonus BioGroup Projected Return Density Against Market
Assuming the 90 days horizon Bonus BioGroup has a beta of 0.37 suggesting as returns on the market go up, Bonus BioGroup average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding Bonus BioGroup will be expected to be much smaller as well.Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Bonus BioGroup or Healthcare sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Bonus BioGroup's price will be affected by overall pink sheet market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Bonus pink sheet's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
Bonus BioGroup has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the Dow Jones Industrial. Predicted Return Density |
Returns |
What Drives a Bonus BioGroup Price Volatility?
Several factors can influence a pink sheet's market volatility:Industry
Specific events can influence volatility within a particular industry. For instance, a significant weather upheaval in a crucial oil-production site may cause oil prices to increase in the oil sector. The direct result will be the rise in the stock price of oil distribution companies. Similarly, any government regulation in a specific industry could negatively influence stock prices due to increased regulations on compliance that may impact the company's future earnings and growth.Political and Economic environment
When governments make significant decisions regarding trade agreements, policies, and legislation regarding specific industries, they will influence stock prices. Everything from speeches to elections may influence investors, who can directly influence the stock prices in any particular industry. The prevailing economic situation also plays a significant role in stock prices. When the economy is doing well, investors will have a positive reaction and hence, better stock prices and vice versa.The Company's Performance
Sometimes volatility will only affect an individual company. For example, a revolutionary product launch or strong earnings report may attract many investors to purchase the company. This positive attention will raise the company's stock price. In contrast, product recalls and data breaches may negatively influence a company's stock prices.Bonus BioGroup Pink Sheet Risk Measures
Assuming the 90 days horizon the coefficient of variation of Bonus BioGroup is -922.81. The daily returns are distributed with a variance of 36.51 and standard deviation of 6.04. The mean deviation of Bonus BioGroup is currently at 1.89. For similar time horizon, the selected benchmark (Dow Jones Industrial) has volatility of 0.72
α | Alpha over Dow Jones | -0.69 | |
β | Beta against Dow Jones | 0.37 | |
σ | Overall volatility | 6.04 | |
Ir | Information ratio | -0.13 |
Bonus BioGroup Pink Sheet Return Volatility
Bonus BioGroup historical daily return volatility represents how much of Bonus BioGroup pink sheet's daily returns swing around its mean - it is a statistical measure of its dispersion of returns. The company shows 6.0422% volatility of returns over 90 . By contrast, Dow Jones Industrial accepts 0.7328% volatility on return distribution over the 90 days horizon. Performance |
Timeline |
About Bonus BioGroup Volatility
Volatility is a rate at which the price of Bonus BioGroup or any other equity instrument increases or decreases for a given set of returns. It is measured by calculating the standard deviation of the annualized returns over a given period of time and shows the range to which the price of Bonus BioGroup may increase or decrease. In other words, similar to Bonus's beta indicator, it measures the risk of Bonus BioGroup and helps estimate the fluctuations that may happen in a short period of time. So if prices of Bonus BioGroup fluctuate rapidly in a short time span, it is termed to have high volatility, and if it swings slowly in a more extended period, it is understood to have low volatility.
Please read more on our technical analysis page.Bonus BioGroup Ltd., a biotechnology company, develops technology solutions to generate tissue-regenerating bone grafts. Bonus BioGroup Ltd. was founded in 1981 and is based in Haifa, Israel. Bonus Biogroup is traded on OTC Exchange in the United States.
Bonus BioGroup's stock volatility refers to the amount of uncertainty or risk involved with the size of changes in its stock's price. It is a statistical measure of the dispersion of returns on Bonus Pink Sheet over a specified period of time, often expressed as the standard deviation of daily returns. In other words, it measures how much Bonus BioGroup's price varies over time.
3 ways to utilize Bonus BioGroup's volatility to invest better
Higher Bonus BioGroup's stock volatility means that the price of its stock is changing rapidly and unpredictably, while lower stock volatility indicates that the price of Bonus BioGroup stock is relatively stable. Investors and traders use stock volatility as an indicator of risk and potential reward, as stocks with higher volatility can offer the potential for more significant returns but also come with a greater risk of losses. Bonus BioGroup stock volatility can provide helpful information for making investment decisions in the following ways:- Measuring Risk: Volatility can be used as a measure of risk, which can help you determine the potential fluctuations in the value of Bonus BioGroup investment. A higher volatility means higher risk and potentially larger changes in value.
- Identifying Opportunities: High volatility in Bonus BioGroup's stock can indicate that there is potential for significant price movements, either up or down, which could present investment opportunities.
- Diversification: Understanding how the volatility of Bonus BioGroup's stock relates to your other investments can help you create a well-diversified portfolio of assets with varying levels of risk.
Bonus BioGroup Investment Opportunity
Bonus BioGroup has a volatility of 6.04 and is 8.27 times more volatile than Dow Jones Industrial. Compared to the overall equity markets, volatility of historical daily returns of Bonus BioGroup is higher than 53 percent of all global equities and portfolios over the last 90 days. You can use Bonus BioGroup to protect your portfolios against small market fluctuations. The pink sheet experiences a normal downward fluctuation but is a risky buy. Check odds of Bonus BioGroup to be traded at $0.0198 in 90 days.Significant diversification
The correlation between Bonus BioGroup and DJI is 0.04 (i.e., Significant diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Bonus BioGroup and DJI in the same portfolio, assuming nothing else is changed.
Bonus BioGroup Additional Risk Indicators
The analysis of Bonus BioGroup's secondary risk indicators is one of the essential steps in making a buy or sell decision. The process involves identifying the amount of risk involved in Bonus BioGroup's investment and either accepting that risk or mitigating it. Along with some common measures of Bonus BioGroup pink sheet's risk such as standard deviation, beta, or value at risk, we also provide a set of secondary indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
Risk Adjusted Performance | (0.07) | |||
Market Risk Adjusted Performance | (1.73) | |||
Mean Deviation | 1.84 | |||
Coefficient Of Variation | (937.06) | |||
Standard Deviation | 5.95 | |||
Variance | 35.4 | |||
Information Ratio | (0.13) |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential pink sheets, we recommend comparing similar pink sheets with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Bonus BioGroup Suggested Diversification Pairs
Pair trading is one of the very effective strategies used by professional day traders and hedge funds capitalizing on short-time and mid-term market inefficiencies. The approach is based on the fact that the ratio of prices of two correlating shares is long-term stable and oscillates around the average value. If the correlation ratio comes outside the common area, you can speculate with a high success rate that the ratio will return to the mean value and collect a profit.
The effect of pair diversification on risk is to reduce it, but we should note this doesn't apply to all risk types. When we trade pairs against Bonus BioGroup as a counterpart, there is always some inherent risk that will never be diversified away no matter what. This volatility limits the effect of tactical diversification using pair trading. Bonus BioGroup's systematic risk is the inherent uncertainty of the entire market, and therefore cannot be mitigated even by pair-trading it against the equity that is not highly correlated to it. On the other hand, Bonus BioGroup's unsystematic risk describes the types of risk that we can protect against, at least to some degree, by selecting a matching pair that is not perfectly correlated to Bonus BioGroup.
Complementary Tools for Bonus Pink Sheet analysis
When running Bonus BioGroup's price analysis, check to measure Bonus BioGroup's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bonus BioGroup is operating at the current time. Most of Bonus BioGroup's value examination focuses on studying past and present price action to predict the probability of Bonus BioGroup's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bonus BioGroup's price. Additionally, you may evaluate how the addition of Bonus BioGroup to your portfolios can decrease your overall portfolio volatility.
Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
Stocks Directory Find actively traded stocks across global markets | |
Bonds Directory Find actively traded corporate debentures issued by US companies | |
Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes |